SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-18-056564
Filing Date
2018-10-31
Accepted
2018-10-31 19:24:01
Documents
1
Period of Report
2018-09-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv506010_3.html 3  
1 OWNERSHIP DOCUMENT tv506010_3.xml 3 6211
  Complete submission text file 0001144204-18-056564.txt   7979
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Issuer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address LEVEL 12, INTERNATIONAL COMMERCE CENTRE 1 AUSTIN ROAD WEST HONG KONG K3 HK
Business Address LEVEL 12, INTERNATIONAL COMMERCE CENTRE 1 AUSTIN ROAD WEST HONG KONG K3 HK 36698324
Wealth Strategy Holding Ltd (Reporting) CIK: 0001723544 (see all company filings)

State of Incorp.: K3 | Fiscal Year End: 0331
Type: 3 | Act: 34 | File No.: 000-20713 | Film No.: 181151531